The U.S. Department of Health and Human Services (HHS) delayed until March 22 a rule that would prevent pharmacy benefit managers (PBMs) from keeping drug rebates paid by drugmakers under Medicare Part D. The delay comes after the Pharmaceutical Care Management Association (PCMA), which represents PBMs, filed a federal lawsuit to block implementation of the rule.
